1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. LUPIN LTD.
Lupin Ltd.
NSE: LUPIN | BSE: 500257
Mid-range Performer
Download real time
US FDA Inspections
Ask MarketMind AI
2415.00 -6.20 (-0.26%)
Near 52W High of ₹2529.50
1.0M
NSE+BSE Volume

NSE 31 Jul, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
US FDA Approval
Lupin gets US FDA nod for ANDA for Sugammadex injection, with an estimated market size of $1.6 bn See details

Lupin - LUPIN - stock price prediction, stock forecast, target price, analyst ratings from 37 analysts

Lupin has a share price target of Rs 2489, revenue growth forecast of 6.7%, and profit growth estimate of -14.0% for FY27, based on top 37 analyst calls.

Forecaster Screeners